+
+

Update to Chapter 138: Blood Procurement and Red Cell Transfusion

+

Zika virus (ZIKV) is a mosquito-borne virus that has several secondary means of transmission including perinatal and sexual modes. Evidence for transmission of Zika virus by blood and platelet transfusion led to the Food and Drug Administration (FDA) issuing new guidelines for Zika testing. The FDA has recommended screening the entire blood supply of the United States for the Zika virus. The Red Cross plans to phase in universal testing.

References +
+
Motta  IJF, Spencer  BR, Cordeira da Silva  S,  et al: Evidence for transmission of Zika virus by platelet transfusion. N Eng J Med Aug 17 2016 10.1056/NEJMc1607262
[PubMed: 27532622]
+
Grischott  F, Puhan  M, Hatz  C, Schlagenhauf: Non-vector-borne transmission of Zika virus: A systematic review. Travel Med Inf Dis 4:313, 2016.
[PubMed: 27425793]
+
Kuehnert  MJ, Epstein  JS: Assuring blood safety and availability: Zika virus, the latest emerging infections disease battlefront. Transfusion 56:1669, 2016.
[PubMed: 27389990]